TrialBlood advances2025

Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study.

Bei Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.